Literature DB >> 23407433

How to advocate for the inclusion of chronic kidney disease in a national noncommunicable chronic disease program.

Marcello Tonelli1, Sanjay Agarwal2, Alan Cass2, Guillermo Garcia Garcia2, Vivek Jha2, Sarala Naicker2, HaiYan Wang2, Chih-Wei Yang2, Donal O'Donoghue2.   

Abstract

Many countries are developing or refining national strategies for noncommunicable chronic disease (NCD) prevention and control. Chronic kidney disease (CKD) is a cause and consequence of other NCDs; CKD acts as a risk multiplier for all four key NCDs as specified by the World Health Organization; CKD is associated with high health-care costs; CKD is readily identifiable; and treatment of CKD is cost-effective and improves outcomes. These observations argue in favor of including CKD in national NCD programs. The purpose of this article is to outline key steps in advocating for the inclusion of CKD in national NCD strategies.

Entities:  

Mesh:

Year:  2013        PMID: 23407433     DOI: 10.1038/ki.2012.488

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  8 in total

1.  Effects of fish oil during hemodialysis on nutritional status and quality of life: a randomized double-blinded trial.

Authors:  Chi Zhang; Chang Ge; Junsheng Wang; Dong Sun
Journal:  Food Nutr Res       Date:  2020-08-03       Impact factor: 3.894

2.  Chronic kidney disease and the global NCDs agenda.

Authors:  Brendon Lange Neuen; Steven James Chadban; Alessandro Rhyl Demaio; David Wayne Johnson; Vlado Perkovic
Journal:  BMJ Glob Health       Date:  2017-07-06

3.  A Summary of Worldwide National Activities in Chronic Kidney Disease (CKD) Testing.

Authors:  Roberto Ruiz-Arenas; Rosa Sierra-Amor; David Seccombe; Stella Raymondo; Maria Stella Graziani; Mauro Panteghini; Tewogbade A Adedeji; Shanthi Naidu Kamatham; Vanja Radišić Biljak
Journal:  EJIFCC       Date:  2017-12-19

4.  Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function.

Authors:  Brendon L Neuen; Toshiaki Ohkuma; Bruce Neal; David R Matthews; Dick de Zeeuw; Kenneth W Mahaffey; Greg Fulcher; Mehul Desai; Qiang Li; Hsiaowei Deng; Norm Rosenthal; Meg J Jardine; George Bakris; Vlado Perkovic
Journal:  Circulation       Date:  2018-10-09       Impact factor: 29.690

5.  Estimates of the 2016 global burden of kidney disease attributable to ambient fine particulate matter air pollution.

Authors:  Benjamin Bowe; Yan Xie; Tingting Li; Yan Yan; Hong Xian; Ziyad Al-Aly
Journal:  BMJ Open       Date:  2019-05-09       Impact factor: 2.692

6.  Incidence of chronic kidney disease hospitalisations and mortality in Espírito Santo between 1996 to 2017.

Authors:  Wesley de Souza; Luiz Carlos de Abreu; Leonardo Gomes da Silva; Italla Maria Pinheiro Bezerra
Journal:  PLoS One       Date:  2019-11-07       Impact factor: 3.240

Review 7.  Chronic kidney disease in Cameroon: a scoping review.

Authors:  Jerry Brown Aseneh; Ben-Lawrence A Kemah; Stephane Mabouna; Mbeng Emmanuel Njang; Domin Sone Majunda Ekane; Valirie Ndip Agbor
Journal:  BMC Nephrol       Date:  2020-09-23       Impact factor: 2.388

8.  Flacourtia indica fruit extract modulated antioxidant gene expression, prevented oxidative stress and ameliorated kidney dysfunction in isoprenaline administered rats.

Authors:  Saima Selim; Noushin Akter; Shariful Islam Nayan; Faizul Islam Chowdhury; Nadia Saffoon; Ferdous Khan; Khondoker Shahin Ahmed; Md Iqbal Ahmed; Mohammad Maqsud Hossain; Md Ashraful Alam
Journal:  Biochem Biophys Rep       Date:  2021-05-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.